Methods blog · Drug Repositioning & Network Medicine

Network proximity & separation

Cyclosporine + selinexor against SARS-CoV-2: a network-medicine case for complementary exposure

Interactome-based proximity, functional proximity and topological separation show that cyclosporine and selinexor target complementary SARS-CoV-2 modules, viral replication and cytokine storm.

#network medicine#drug combination#SARS-CoV-2#interactome#network separation

Two hallmark features of severe COVID-19 are enhanced viral replication and a subsequent cytokine storm. Two existing drugs had each shown activity against SARS-CoV-2 through one of these routes:

  • cyclosporine, an immunosuppressant (relevant to the cytokine storm);
  • selinexor, an inhibitor of the nuclear export protein XPO1 (relevant to viral replication).

Because the pathology is multifactorial, a monotherapy is unlikely to be optimal. We asked whether network medicine supports combining them.

The framework

All analyses run on an integrated human interactome. For each drug we define a drug module (its targets in the network) and compare it with SARS-CoV-2 disease modules (host proteins perturbed by infection).

  1. Disease proximity: are a drug’s targets closer to the disease module than random target sets? We compute a network distance and assess it against randomised expectations.
  2. Functional proximity: do the drug and disease modules share enriched biological functions?
  3. Topological separation between the two drug modules \(A\) and \(B\), for example with the separation measure widely used in network medicine:
\[s_{AB} \;=\; \langle d_{AB} \rangle \;-\; \frac{\langle d_{AA} \rangle + \langle d_{BB} \rangle}{2},\]

where \(\langle d_{AB}\rangle\) is the mean shortest distance between the two modules and \(\langle d_{AA}\rangle\) and \(\langle d_{BB}\rangle\) are the within-module distances. A positive \(s_{AB}\) means the two drugs act on topologically separate neighbourhoods.

All results are tested for statistical significance.

Findings

  • Both drug-target modules are highly proximal to SARS-CoV-2 disease modules, topologically and functionally, and significantly so for each drug on its own.
  • Functional enrichment shows the two drugs target functions related to viral replication and cytokine storm, respectively.
  • The two drug modules are well separated in the network. Each drug hits the disease module, but from a different side: a pattern known as complementary exposure, which network-medicine studies have associated with effective combinations.

Implication

Cyclosporine plus selinexor is a rational candidate combination that warrants in vitro and in vivo testing, and ultimately clinical evaluation. The analysis also illustrates the general workflow we first built into COVID-CDR, now being extended to cancer in the proposed Onco-CDR platform.

Read the paper

BibTeX